Compound ID | 3588
Synonym(s): A49759 | ODMF
Class: Aminoglycoside
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Enterobacter sp., Serratia marcescens, Shigella sp., and Salmonella sp. |
| Description: | Semisynthetic compound derived from the natural product fortimicin A; shows synergistic effect with carbenicillin; shows efficacy in mice infected with Klebsiella pneumoniae. Staphylococcus aureus, Escherichia coli, or Pseudomonas aeruginosa |
| Institute where first reported: | Abbott Laboratories |
| Year first mentioned: | 1980 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/12900379 |
| Citation: | https://journals.asm.org/doi/epdf/10.1128/aac.18.5.766 |